| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 8.46 | 9.68 |
| Operating profit | 0.55 | 0.6 |
| Net profit | 0.39 | 0.41 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹8.23 | ₹6.40 | ₹6.35 | ₹6.38 |
| Other Income | ₹0.23 | ₹0.04 | ₹0.02 | ₹0.07 |
| Total Revenue | ₹8.46 | ₹6.44 | ₹6.36 | ₹6.46 |
| Total Expenses | ₹7.91 | ₹5.93 | ₹5.50 | ₹5.75 |
| Profit Before Tax | ₹0.55 | ₹0.51 | ₹0.86 | ₹0.70 |
| Tax | ₹0.16 | ₹0.13 | ₹0.25 | ₹0.19 |
| Profit After Tax | ₹0.39 | ₹0.37 | ₹0.61 | ₹0.51 |
| EPS - Basic | ₹1.90 | ₹2.37 | ₹4.09 | ₹3.42 |
| EPS - Diluted | ₹1.90 | ₹2.37 | ₹4.09 | ₹3.42 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹0.55 | ₹0.51 | ₹0.86 | ₹0.70 |
| Income before WC changes | ₹0.85 | ₹1.01 | ₹1.27 | ₹1.01 |
| Change in Assets | -₹2.25 | -₹0.91 | ₹0.10 | ₹0.03 |
| Change in Liabilities | ₹0.69 | -₹1.23 | ₹0.18 | ₹0.12 |
| Change in WC | -₹1.57 | -₹2.14 | ₹0.28 | ₹0.15 |
| Cash flow from Operations | -₹0.88 | -₹1.28 | ₹1.25 | ₹0.96 |
| Cash flow from Investing | -₹0.73 | ₹0.75 | -₹0.65 | -₹1.47 |
| Cash flow from Financing | ₹3.98 | ₹0.45 | ₹0.09 | ₹0.29 |
| Total Cash Flow | ₹2.37 | -₹0.08 | ₹0.68 | -₹0.22 |
| Cash (Start of the year) | ₹0.70 | ₹0.78 | ₹0.10 | ₹0.32 |
| Cash (End of the year) | ₹3.07 | ₹0.70 | ₹0.78 | ₹0.10 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹3.37 | ₹2.90 | ₹4.07 | ₹2.30 |
| Current Assets | ₹7.34 | ₹2.71 | ₹1.96 | ₹1.38 |
| Total Assets | ₹10.71 | ₹5.61 | ₹6.03 | ₹3.69 |
| Current Liabilities | ₹1.68 | ₹1.63 | ₹1.76 | ₹1.36 |
| Net Current Asset | ₹5.66 | ₹1.08 | ₹0.21 | ₹0.02 |
| Non-Current Liabilities | ₹0.20 | ₹0.43 | ₹1.90 | ₹0.48 |
| Equity Capital | ₹8.83 | ₹3.55 | ₹2.38 | ₹1.85 |
| Total Equity & Liabilities | ₹10.71 | ₹5.61 | ₹6.03 | ₹3.69 |
Clinitech Laboratory Limited is engaged in the business of providing pathology and related healthcare services. It is a provider diagnostic and healthcare tests and services through a chain of diagnostic centers in and around Thane and Navi Mumbai. It conducts more than 150 tests at its centers, which are classified under various heads, such as biochemistry tests, immunology tests, hematology tests, molecular biology tests, serology tests, microbiology tests, and histopathology tests, among others. Its serology test is used to detect antibodies in the blood, which are produced by the immune system in response to infections or other foreign substances. Its microbiology test is used for identifying the causative agents of infections, determining their susceptibility to antibiotics, and monitoring treatment efficacy. It offers various test packages, including CTL Silver, CTL Gold, CTL Diamond For Him, CTL Diamond For Her, CTL Platinum, CTL Deluxe (full body), and CTL Royal (full body).
Clinitech Laboratory Limited share price is ₹42.00 as on 30 Jun, 2026, 12:11 IST.
The Mutual Fund Shareholding in Clinitech Laboratory Limited was 0.00% at the end of Mar 2026.
The 52-week high and low of Clinitech Laboratory Limited share is ₹57.00 and ₹28.55 as of 30 Jun, 2026.
The market capitalisation of Clinitech Laboratory Limited is ₹9.59 Crores as on 30 Jun, 2026.
The stock symbol of Clinitech Laboratory Limited is 544220 on the BSE, and the ISIN is INE0QMR01015.
Clinitech Laboratory Limited shares closed yesterday at ₹42.00 on BSE
To buy Clinitech Laboratory Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of Clinitech Laboratory Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Clinitech Laboratory Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of Clinitech Laboratory Limited is 22.7 and 1.04 respectively, as on 30 Jun, 2026, 12:11 IST.